Ratio Therapeutics
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers.
Location: New York, NY
Foundation Cornell Technology Licensed: 2021